Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$2.64 - $4.84 $1.21 Million - $2.22 Million
-458,732 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$3.5 - $5.3 $3.38 Million - $5.12 Million
-966,250 Reduced 67.81%
458,732 $1.99 Million
Q4 2021

Feb 11, 2022

SELL
$4.45 - $6.21 $333,830 - $465,861
-75,018 Reduced 5.0%
1,424,982 $7.38 Million
Q3 2021

Nov 12, 2021

BUY
$6.14 - $10.1 $6.14 Million - $10.1 Million
1,000,000 Added 200.0%
1,500,000 $9.21 Million
Q2 2021

Aug 13, 2021

BUY
$9.04 - $14.19 $4.52 Million - $7.1 Million
500,000 New
500,000 $5.05 Million

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $297M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.